Pulmatrix, Inc.
corporate_fare Company Profile
Pulmatrix, Inc. (NASDAQ:PULM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for PULM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for PULM spans 8-K, DEFM14A, S-4/A, 10-Q.
Recent high-impact activity:
- Pulmatrix Q3: Cash Down to $1.4M, Going Concern, Merger Closing by Year-End
- Pulmatrix Targets November Close for Eos Merger as Cash Falls to $1.4M
- Pulmatrix Stockholders Approve Eos SENOLYTIX Reverse Merger and Reverse Split
- Pulmatrix Mails Definitive Proxy for Eos SENOLYTIX Reverse Merger Vote on October 16
- Pulmatrix Sets October 16 Vote on Eos SENOLYTIX Reverse Merger, Updates Exchange Ratio to 8.55
Financial Snapshot
Short Interest & Short Volume
1.32 days to coverFINRA reported short interest of 39,538 shares in PULM as of the October 30, 2026 settlement, a 8.5% decrease from the prior period — about 1.3 days to cover at its recent average daily volume. On November 20, 2026, 13.7% of PULM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PULM, detected from its recent SEC filings · based on capital-structure filings through 2026-10-26.
Resale Prospectus Finalized · No Proceeds to Company
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →